http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02083173-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6496081d3a5d93055ba0c091eb44b49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3891f28851864de2418fe979c102bd1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9adc081dbce09a57276f0fc0b4a03c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec0024795f45a646ef64b3664ab8a26d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
filingDate 2002-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3aded90045e53fa8faac24b6ed0c61e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c613dbecd456b43ca575f9219548ed6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c16d9f36cea59b8c1471e2a4ac7080b
publicationDate 2002-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-02083173-A1
titleOfInvention Use of an histone deacetylase inhibitor for the treatment of diseases associated with an hpv infection
abstract Described is the use of histone deacetylase inhibitors for the treatment of a disease, preferably cervical cancer, associated with an HPV infection. Particularly useful inhibitors are sodium butyrate, phenylbutyrate and trichostatin A.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7732475-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7741494-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7611729-B2
priorityDate 2001-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414426
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127922471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128784833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405512
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID457193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129179142
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7012
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127978224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128611546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID547739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135968306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444732
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394363
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54078102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394364
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2019

Total number of triples: 57.